Vanguard Asset Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
Vanguard Asset Management's CRL Position: Q3 2026 in Review
Vanguard Asset Management increased its Charles River Laboratories (CRL) stake by 5.9% in Q3 2026, buying an estimated $723K and bringing the position to 48,922 shares worth $14.4M. The position accounts for 0.01% of the portfolio, ranked #588.
Vanguard Asset Management first reported a position in CRL in Q1 2026 and has held it in 3 quarters since. 642 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- Vanguard Asset Management held 48,922 shares of Charles River Laboratories worth $14.4M as of Q3 2026.
- Vanguard Asset Management bought 2,745 Charles River Laboratories shares in Q3 2026, an estimated $723K.
- Charles River Laboratories made up 0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #588 holding.
- Vanguard Asset Management first reported a position in Charles River Laboratories in Q1 2026 and has held it in 3 quarters since.
- 642 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.